We assessed risk of transmission among 4,016 HIV-infected patients in primary care, including men who have sex with men (MSM, n = 2,109), women (n = 1,104) and men who had sex with women (MSW, n = 803) in clinics in 15 cities across the U.S. A transmission risk act, assessed by computer assisted interviews, was defined as unprotected vaginal or anal sex with a partner who was HIV-uninfected or of unknown HIV status. MSM were more than twice as likely to report transmission risk acts than MSW (Odds Ratio [OR] = 2.35; 95% Confidence Interval [CI] = 1.84, 3.00; P £ .001). Women were also more likely to report transmission risk acts than MSW (OR = 1.56; 95% CI = 1.19, 2.05; P £ .001). Stimulant use was associated with transmission risk in all three groups (P £ .05). MSM were more likely to use methamphetamines (8% versus 2% and 3% respectively), while MSW (17%) and women (12%, compared to 11% for MSM) were more likely to use cocaine. Clinical settings offer opportunities for preventing HIV transmission, particularly if interventions are tailored to sub-populations of HIV-infected patients.
Introduction
Clinical care settings offer opportunities for HIV ''prevention with positives.'' Yet, prior research conducted with patients exiting primary HIV care visits in Ryan White CARE Act funded clinics found that this opportunity is frequently missed . Only six percent of patients had discussed specific sexual risk during their office visit, suggesting that both screening for risk and counseling for prevention of transmission were infrequent. Furthermore, HIV transmission risk counseling was reported significantly less often than other prevention counseling for adherence to antiretroviral therapy, emotional issues or diet and nutrition. Nonetheless, patients in clinics with written procedures for HIV prevention with positives were significantly more likely to report receiving such counseling .
In response to recommendations from both the Centers for Disease Control and Prevention (CDC, 2003) and the Institute of Medicine (Institute of Medicine, 2001) , the Health Resources and Services Administration, which administers the Ryan White program, has sponsored a 5-year initiative to develop and evaluate HIV prevention services in clinical settings. Fifteen sites received awards to tailor evidence-based prevention approaches to their settings and populations (see Malitz and Eldred in this issue). These projects have involved a variety of individual and group interventions delivered by providers, specialist or peers (see Koester and colleagues in this issue).
The goal of this analysis is to determine the frequency of transmission risk acts and the predictors of risk behavior among participants recruited at baseline in the fifteen clinics participating in the initiative. We also assess differences across subpopulations-men and men who have sex with men (MSM), women, and men who have sex with women (MSW)-to assess issues important for HIV prevention planning.
Methods
Survey interviews were conducted in 15 Ryan White-funded clinics between April 2004 and December 2006. The clinics were selected based on a competitive application process. Clinics were located in Chapel Hill, NC; Boston, MA; Baltimore, MD; New Your City, NY; Seattle, WA; Sacramento, CA; San Diego, CA; Birmingham, AL; Philadelphia, PA; Los Angeles, CA; Washington, DC; Decatur, GA; Miami, FL, Chicago, IL; and Tucson, AZ. Each site required local human subjects approval in addition to the approval obtained from the University of California, San Francisco, which serves as the cross site evaluation center.
Participants and Recruitment
A total of 4,016 HIV-infected patients completed standard cross-site interviews as well as any site-specific interviews. Inclusion criteria were HIV-infected status, receipt of primary care at the clinic, age of 18 years or older, and ability to provide informed consent. For the cross-site evaluation, we translated the interview instrument into Spanish, however this version was used at only one site. All other respondents were English-speaking. Sites had the option of adding additional inclusion requirements. The cross-site evaluation survey took approximately 30 min to complete.
Recruitment and screening of potential respondents were undertaken exclusively in medical clinics serving HIV-infected clients. Sites used a variety of recruitment materials including brochures, posters, and project descriptions, as well as direct contact by study staff in clinics. In most cases, interested persons agreeing to participate were briefly screened by project personnel to determine their self-reported HIV status as well as basic demographic and contact information. Then, eligible participants were scheduled for a baseline interview. Screening most often took place in a private setting, usually in a room or quiet place in the clinic. Most sites used incentives to encourage participation in the evaluation portion of the project such as cash, a grocery voucher or gift certificate.
Measures
Assessment interviews were conducted using a combination of audio computer-assisted self-interviewing (ACASI) and computer-assisted personal interviewing (CAPI) procedures based on the Questionnaire Development System version 2.0 by Nova Research Co. (Bethesda, MD). ACASI allows respondents to listen to an item via headphones while reading the text of that item on the computer monitor. The respondent then enters a response directly into the computer. This approach is designed to decrease social desirability bias and thereby enhance validity of selfreports of sensitive behaviors and attitudes (Gribble, Miller, Rogers, & Turner, 1999; Turner et al., 1998) . CAPI involves an interviewer reading items from a computer and allowing the respondent to make verbal responses that are entered directly into the computer by the interviewer. Both ACASI and CAPI eliminate a separate data entry process and may therefore reduce data errors.
Demographic Characteristics and Health Status Indicators
Detailed background and demographic items included participant age, race/ethnicity, gender, self-identified sexual orientation, relationship status, educational level, employment status, and income. In addition, health status indicators were assessed, including self-reported most recent CD4 count, HIV viral load, and current use of antiretroviral medication.
Sexual Behavior
A detailed interview was developed to assess sexual behavior over a 6-month recall period (Morin et al., 2005; Steward, Koester, Myers, & Morin, 2006; Myers et al., 2004; Morin et al., 2004; Westbrook, & Bauman, 1996) . Separate but equivalent versions of questions were developed for men and women, each with language tailored to be consistent with the participant's gender and sexual orientation. The interview began with an introduction and definition of sexual terms to minimize ambiguity. Men were then asked if they had engaged in any sexual activity during the previous 6 months with men, women, or both and the number of partners of each sex. Women in this study were only asked about sex with men. Based on responses to these items, the computer-based interview asked pertinent questions about sexual behavior.
Participants were asked to provide the number of times they had engaged in insertive or receptive vaginal or anal sex with HIV-infected partners, HIV-uninfected partners and partners of unknown HIV status. Participants were also asked about the number of times they had used condoms (male or female) from the beginning to the end of penetration and the number of times sex was unprotected. Unprotected sex was limited in the questioning to any act of insertive or receptive anal or vaginal intercourse in which a participant did not use a condom, a definition that excludes risk acts produced by accidental condom slippage or breakage.
Substance Use
Use of legal and illegal substances was assessed over a 3-month recall period (Purcell et al., 2004) . Items included alcohol, cocaine/crack, sedatives, tranquilizers, stimulants (such as crystal methamphetamine), analgesics, inhalants, marijuana, hallucinogens, and heroin. Use of injected drugs was assessed over the past 30 days. Items included frequency of injection and whether a participant had lent a needle to someone else after using it.
Statistical Analysis
The primary aim of this analysis was to assess which participant characteristics were associated with sexual transmission risk behavior among MSM, women and MSW in this sample of HIV-infected individuals in care.
Risk Groups
For purposes of this analysis, men were considered MSM if they reported any sexual contact with other men in the past 6 months. Men were placed in the heterosexual category if they only had sexual contact with women in the past 6 months. When men indicated they had had no sexual contact in the past 6 months, we categorized them based on their self-identified orientation. Women were categorized based on their-self identified gender. Participants identifying as transgender (n = 69) were excluded from this analysis.
Transmission Risk Acts
For purposes of this analysis, transmission risk acts were defined as reports of unprotected anal or vaginal intercourse without the use of a condom with any HIV-uninfected or unknown status partners.
Coding Substance Use
Because alcohol and stimulants were specifically associated with risk in previous studies (Colfax et al., 2005; Halkitis, Parsons, & Stirratt, 2001; Koblin et al., 2003) , we examined them separately. We aggregated the assessments of the remaining drugs into one variable labeled ''other drug use.'' Because data for the stimulant and other drug use variables were skewed (i.e., most participants indicated no or little use), we dichotomized the responses into two indicator variables (0 = no use of substance; 1 = use of substance). Alcohol use was more prevalent so we created variables to code for three categories of usage: none, less than daily, and daily.
Analytical Approach
First, we selected participant characteristics that we hypothesized might be associated with sexual risk behavior based on prior research. We then examined the relative number and proportion of total sex acts and unprotected sex acts that were reported among MSM compared to MSW and women compared to MSW using chi-squared tests of homogeneity for categorical variables and non-parametric Wilcoxon rank-sum tests for continuous variables.
Next, we created univariable logistic regression models to assess which participant characteristics was associated with sexual risk behavior overall and among MSM, women and MSW. We collapsed sexual risk data into a dichotomous indicator variable (0 = no transmission-risk sex acts; 1 = any transmission-risk sex acts). This indicator was used as the dependent variable in logistic regression models examining the effect of demographic characteristics (sexual identity, race, education, employment, age), health status (CD4 cell count, viral load, current use of antiretroviral therapy), and drug use (alcohol, stimulants). We modeled the relationship between participant characteristics and sexual risk behavior among MSM, women and MSW using multivariable logistic regression. Characteristics that were associated with sexual risk behavior at the P £ .05 were included in each of these models. We fit additional models using generalized estimating equations (GEE) to adjust for the clustered nature of data across sites. The estimates from these models were similar to those presented above.
Transmission Risk Estimates
Finally, we estimated the total number of new HIV infections due to sexual risk behavior among participants using the approach taken in assessing the impact of prevention with positives; based on published probabilities (Weinhardt et al., 2004) , for each study participant, we estimated the probability that he or she would transmit HIV as the sum of the transmission probabilities for each sex act. Because we do not have information on sexual behavior with individual sex partners, it was necessary to assume that an individual's sexual behavior, and therefore the probability of transmission of HIV, was similar with sexual partners of the same gender and HIV status. Therefore, for each study participant, (i) we modeled the estimated number of HIV transmissions,T ij , to HIV-uninfected male, HIV-uninfected female, unknown status male or unknown status female sex partners (j) using the following equation:
In this equation, n denotes the number of sexual partners of a particular gender and HIV status, a, b, c, and d denote the number of unprotected sex acts (insertive and receptive anal and vaginal intercourse for heterosexual male participants and receptive anal and vaginal intercourse for female participants) with individuals of a particular gender and HIV status, HIV status, and a a , a b , a c , and a d represent the associated per-act transmission probabilities (.0006 for unprotected receptive and vaginal intercourse, .001 for unprotected insertive vaginal intercourse, and .02 for unprotected insertive anal intercourse). The l parameter represents the reduction in transmission because of antiretroviral therapy: l was set at .50 for those who reported being on antiretroviral therapy and 0 otherwise. The k parameter denotes the probability that the partner was already infected with HIV: k was set to 0 for HIV-uninfected sexual partners, .01 for unknown HIV status opposite gender partners, and .30 for unknown HIV status male partners of men.
Results

Demographic and Health Status Characteristics
The overall sample contained 4,016 participants. Of these, 2,109 (52.5%) were classified as MSM, 1,104 (27.5%) as women and 803 (20.0%) as MSW. Table 1 displays participants' demographic characteristics, health status, and drug use within these three categories. African Americans made up the largest proportion of patients across categories of race and ethnicity (48%). Women and MSW were more likely to be African American (68% for both) than MSM (29%; P £ .001 for both). As expected, the majority of MSM self-identified as homosexual (84%), and most women and men who had sex with women only (MSW) identified as heterosexual (89% and 96%, respectively). However, approximately 8% of women compared to only 3% of MSW identified as gay or bisexual (P £ .001). Both MSM and women were more likely than MSW to be under 40 years of age (P £ .001 for both). MSM were more likely than MSW to have completed some college (P £ .001) and to be employed (P £ .001).
Clinically, MSM were more likely than MSW to report that their current CD4 count was above 200 cell/mm 3 (P £ .001), although there were no significant differences across groups in reported viral load. Women were less likely than all men to be on antiretroviral therapy (P £ .001).
Substance Use
Alcohol use was reported by 71% of MSM, 43% of women and 51% MSW. Women were less likely than MSW to report using alcohol (P £ .001), while MSM were more likely than MSW to report alcohol (P £ .001). Other drug use was reported by 32% of MSM, 16% of women and 23% of MSW. Women (14%) were significantly less likely than MSM (23%; P £ .001) or MSW (20%; P £ .002) to use stimulants. MSM were significantly more likely to use speed or cocaine and speed together (12%) than were MSW (4%; P £ .001) or women (2%; P £ .001). MSW (17%) reported using cocaine more often than women (12%; P £ .014) or MSM (11%; P £ .001).
Injection Drug Use
A small proportion (5%) of patients reported injecting drugs in the past 30 days. Compared to MSW (7%), fewer MSM (4%; P £ .001) and women (3%; P £ .001) reported injecting drugs in the past 30 days. Among those who injected drugs, neither frequency of injection nor the proportion who reported lending a used syringe to another injector varied significantly across groups. Out of the entire sample only 14 individuals reported sharing injection equipment with persons who were HIV negative or of unknown serostatus. Table 2 shows the prevalence of self-reported sexual behaviors and unprotected sex in the last 6 months. Overall, 84% of MSM, 70% of women and 74% of MSW reported at least one sexual partner in the previous 6 months. MSM had more and women had fewer sexual partners compared to MSW (P £ .001 and P = .002, respectively). Note: Excludes transgendered individuals (n = 71, 1% of the sample) S10 AIDS Behav (2007) 11:S6-S16 Approximately 66% of MSM, compared to only 24% of women and 41% of MSW, reported two or more sex partners in the past 6 months (P £ .001 for both relative to MSW).
Sexual Behavior
About half of all individuals reported sex with an HIVuninfected partner. MSM were more likely than women (P £ .001) and MSW (P £ .001) to report sex with partners of unknown status. Types of sexual acts also varied across groups. Almost two-thirds of sexually active MSM reported both anal insertive and anal receptive sex in the past 6 months. Approximately 80% of sexually active women and MSW reported vaginal sex, while approximately 20% of both groups reported anal sex.
Transmission Risk Acts
A total of 23% of MSM, 17% of women and 11% of MSW reported transmission risk acts, i.e. unprotected anal or vaginal intercourse with an HIV-uninfected or unknown status partner in the last 6 months (P £ .001 for both MSM and women compared to MSW). Compared to MSW, MSM were more likely (P £ .001) and women were less likely (P £ .006) to report sex with known HIV-infected partners.
Predictors of Transmission Risk Acts
Overall, MSM were more likely to report transmission risk acts than women [Odds Ratio (OR) = 2.41; 95% Confidence Interval (CI) = 1.85, 3.13; P £ .001] and women more likely to report transmission risk acts than MSW [OR = 1.63; 95% CI = 1.21, 2.19; P £ .001].
In univariable analyses among all participants, additional predictors of sexual transmission risk included having some college education (OR = 1.36; 95% CI = 1.15, 1.60; P £ .001), younger age (>40 years; OR = .48; 95% CI = .41, .56; P £ .001), being employed (OR = 1.74; 95% CI = 1.48, 2.05; P £ .001), any use of alcohol (OR = 1.94; 95% CI = 1.62, 2.32; P £ .001 for less than daily and OR = 2.60; 95% CI = 1.82, 3.72; P £ .001 for daily use of alcohol), the use of stimulants (e.g., methamphetamines or cocaine; OR = 2.44; 95% CI = 2.04, 2.92; P £ .001) and not being on ART (OR = .63; .51, .79; P £ .001). Compared to whites, African Americans and Latinos were significantly less likely to report sexual transmission risk acts (OR = .55; 95% CI = .46, .66; P £ .001 for African Americans and OR = .68; 95% CI = .53, 087; P = .01 for Hispanic/Latino compared to Whites). Clinical status variables (CD4 and viral load) were not associated with risk. Table 3 presents multivariable predictors of transmissionrisk behavior among MSM, women and MSW. In the multivariable model, alcohol and stimulant use were both strong predictors of risk. Men who drank alcohol daily (OR = 2.07; P £ .01) or used stimulants (OR = 2.26; P £ .001) were more than twice as likely to report risk as men who did not drink or use stimulants. Younger men (OR = .54 for 40 + years; P £ .001) and employed men (OR = 1.39; P £ .005) were also significantly more likely to report risk. African American MSM were less likely to report risk (OR = .67; P £ .003).
Predictors of Risk among Men Who Have Sex with Men
Predictors of Risk among Women
In the multivariable model predicting risk among women, stimulant use (OR = 2.03; P £ .003) was also a strong predictor of risk. Moderate use of alcohol (OR = 1.68; P £ .005) was associated with risk as was younger age (OR = .52; P £ .0002). Ethnicity, education, employment and ART use had no effect on reported risk.
Predictors of Risk among Men Who Have Sex with Women
MSW who had a college education (OR = 2.16; P £ .003) and were employed (OR = 1.65; P £ .05) were more likely to report transmission risk. As with women and MSM, stimulant use (OR = 1.69; P £ .05) was also a significant predictor of risk (Fig. 1) .
Epidemic Impact
Based on the self-reported sexual behaviors reported by the participants in this study, 37 at-risk (HIV-uninfected or serostatus unknown) sexual partners would be expected to acquire HIV as a result of sexual intercourse with study participants during the 6-month assessment period. As indicated in Table 4 , partners of MSM accounted for 31 (83.8%) of these new HIV infections, the partners of MSW for 3 (8.1%), and the partners of women for 3 (8.1%). The mean number of new infections per study participant was also greater for MSM (14.8 per 1,000 participants) than for MSW (3.6 per 1,000) or women (2.3 per 1,000). These estimates were sensitive to the per-act transmission probability values used in the analysis: doubling these probabilities increased the total number of infections to 71, whereas halving them decreased the number of infections to 19. The results were also sensitive to the presumed effectiveness of antiretroviral therapy at reducing the probability of HIV transmission, ranging from 21 new infections (assuming that antiretroviral therapy completely eliminates transmission risk) to 51 new infections (assuming antiretroviral therapy has no effect on transmission risk). The results were not particularly sensitive to changes in the condom effectiveness parameter or to the prevalence of infection among women, MSW and MSM in the U.S.
Discussion
While the majority of HIV patients in these clinics were not engaged in transmission risk acts, the frequency of reports provide a strong rationale for prevention with positives in clinical care settings. With 23% of MSM, 17% of women and 11% of MSW reporting transmission risk acts in the last 6 months, risk assessment and counseling could be a cost-efficient approach to HIV prevention in the U.S. Our modeling suggests that in these 15 clinics alone there may be an opportunity to prevent about 68 new infections per year. If this same level of risk of transmission was found at the more than 2,500 provider sites funded under Ryan White (Health Resources and Services Administration HIV/AIDS Bureau, 2004), this would equate to over 17,000 infections per year. Under these circumstances, even interventions with modest efficacy in terms of behavior chance could have significant epidemic impact.
Issues facing MSM continue to be a challenge for HIV prevention in the U.S., where a concentrated epidemic is being maintained at an unacceptably high level. Because of the level of transmission risk acts found among MSM in this sample, our results suggests that the majority of new infections can be expected in this group. This finding is consistent with modeling from another large, but differently recruited, sample of HIV-infected adults (Weinhardt et al., 2004) . Also, as in previous studies, our findings suggest that alcohol and stimulant use-particularly methamphetamine use-predict risk of transmitting HIV among MSM (Morin et al., 2005) . There is growing evidence that stimulant users display decreased adherence to antiretroviral therapy and elevated viral load, which could lead to poorer heath outcomes and resistant virus, which could be transmitted to others (Arnsten et al., 2002; Colfax et al., 2007; Ellis et al., 2003; Hinkin et al., 2007) . Thus, developing specific protocols for screening for risk and counseling with MSM in clinical settings is recommended.
While the risk of transmission found in these clinics was lower for MSW and women, it was not inconsequential. Importantly, risk among heterosexuals was also linked to stimulant use. Consistent with previous research (Colfax et al., 2005; Halkitis et al., 2001; Koblin et al., 2003) , these findings suggest that stimulant use contributes significantly to risk of HIV transmission and that interventions designed to reduce or eliminate its use should be an important component of HIV prevention. Our finding that risk was also associated with education and employment among MSW suggests that they may have the resources to provide cocaine in contexts where sex with women also occurs. Although ethnicity was not a significant predictor of risk for heterosexuals, the majority of respondents in this sample was African American. This is also important to understanding the context of transmission risk because of the challenges posed by cocaine use in some African American communities.
Women reported more unprotected sex with HIV-uninfected and status-unknown partners than did MSW. Because the probability of transmission from a woman to a man during an act of unprotected sex is lower than from a man to a woman in U.S. settings, this may also be evidence that heterosexuals are making decisions about sex based on their knowledge of transmission likelihood and, perhaps, the value of unprotected sex for intimacy and for a desire to have children.
Patients in all groups had more unprotected sex with other HIV-infected individuals than uninfected or unknown status partners, which may indicate some are using ''serosorting'' as a prevention strategy. This was particularly the case for MSM. However, in the context of drug and alcohol use, it may be more difficult to make strategic decisions about reducing risk.
This study has a number of limitations. Because of the competitive selection process, there is no evidence that the 15 clinics are representative of all Ryan White-funded providers. This limits our ability to generalize results. Although the survey sample obtained reflects the demographic characteristics of Ryan White-funded clinics, participating clinics approached patients in different ways, resulting in the unavailability of subject-level participation rates. In addition, these findings are limited by the crosssectional nature of the data. Longitudinal designs are needed to prove definitively cause-and-effect relationships between contextual factors and the likelihood of transmission-risk sex. Finally, the findings are based on self reports of a stigmatized behavior, but the use of computerassisted interviewing should have minimized this potential bias.
While the findings from this study are cause for concern a variety of evidence-based approaches for prevention with positives are now available for clinic settings. A systematic review of HIV behavioral intervention found a number of interventions meeting the criteria of best evidence (Lyles et al., 2007) . Significant intervention effects included increased condom use, reduction in number of unprotected sex acts, reduction in number of partners, reduction in drug use and needle sharing as well as reduction in sexually transmitted diseases. Many of the best-evidence interventions focus on prevention with positives. These include a group-level intervention provided by community-based facilitators (Kalichman, Rompa, & Cage, 2005; Kalichman et al., 2001) , a group-level intervention provided by peer educators for African American women (Wingood et al., 2004) , and a group level intervention provided by peer educators for MSM . Provider-base brief interventions in clinical care setting have also been found to be effective (Fisher et al., 2004; Richardson et al., 2004) . In addition, individual-level interventions provide by trained specialists were found to be effective for high risk, drug-using youth , and more recently for diverse group of MSM and MSW and women based on a prevention case management model (The Healthy Living Project Team, 2007) .
Finally, we believe our findings confirm the importance of involving people being seen in HIV primary care in the development and oversight of clinic-based programs for prevention with positives. People living with HIV often express concern over the possibility of infecting others. They are also keenly aware of the medical and psychological consequences of becoming infected, and they are in an ideal position to take the lead in responding to stigma and discrimination. Thus, forging partnerships with patients living with HIV has enormous potential to make prevention with positives a routine and meaningful part of quality HIV care.
